The authors are all researchers at the Economic and Social Research Council's (ESRC) Centre for Research on Socio Cultural Change at the University of Manchester.Julie Froud is a Reader in Accounting at Manchester Business School.Sukhdev Johal is a Reader in the School of Management, Royal Holloway, University of London.Adam Leaver is a Lecturer in the School of Accounting and Finance at the University of Manchester .Karel Williams is Professor of Accounting and Political Economy at Manchester Business School.

'Financialization and Strategy will be of considerable interest to scholars, managers and policy makers concerned with effects of capital markets on corporate strategy.' -Michael Power,London School of Economics and Political Science, UK

• Part 1: What Corporate Management Has Become 1. Introduction 2. Classical Strategy 3. The Intrusion of the Capital Market 4. Keeping it Going 5. Better Governance? Part 2: Cases 6. Introduction to the Cases 7. General Electric 8. Ford Motor Company 9. GlaxoSmithKline 10. Synthesis

The authors are all researchers at the Economic and Social Research Council's (ESRC) Centre for Research on Socio Cultural Change at the University of Manchester.Julie Froud is a Reader in Accounting at Manchester Business School.Sukhdev Johal is a Reader in the School of Management, Royal Holloway, University of London.Adam Leaver is a Lecturer in the School of Accounting and Finance at the University of Manchester .Karel Williams is Professor of Accounting and Political Economy at Manchester Business School.

'Financialization and Strategy will be of considerable interest to scholars, managers and policy makers concerned with effects of capital markets on corporate strategy.' -Michael Power,London School of Economics and Political Science, UK

• Part 1: What Corporate Management Has Become 1. Introduction 2. Classical Strategy 3. The Intrusion of the Capital Market 4. Keeping it Going 5. Better Governance? Part 2: Cases 6. Introduction to the Cases 7. General Electric 8. Ford Motor Company 9. GlaxoSmithKline 10. Synthesis